Viemed Healthcare, Inc.
VMD Nasdaq
SEC CIK 1729149
Follow Viemed Healthcare
Weekly email: filings, results
Revenue, last quarter
$80.7M
+12.2% vs same quarter last year
Net income
$4.6M
+32% vs same quarter last year
EPS, diluted
$0.11
+22.2% vs same quarter last year
Operating cash flow
$11.5M
−37.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $270.3M | $15.4M |
| FY24 | $224.3M | $11.4M |
| FY23 | $183M | $10.2M |
| FY22 | $138.8M | $6.2M |
| FY21 | $117.1M | $9.1M |
| FY20 | $131.3M | $31.5M |
| FY19 | $80.3M | $8.5M |
| FY18 | $64.5M | $9.5M |
| FY17 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 57.5% | 8.5% | 5.7% |
| FY24 | 59.4% | 8% | 5.1% |
| FY23 | 61.6% | 7.8% | 5.6% |
| FY22 | 61% | 5.9% | 4.5% |
| FY21 | 62.7% | 9.9% | 7.8% |
| FY20 | 61% | 20.4% | 24% |
| FY19 | 69.8% | 11% | 10.6% |
| FY18 | 74.1% | 15.6% | 14.7% |
| FY17 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $11.9M |
| FY24 | $1.3M |
| FY23 | $19.1M |
| FY22 | $4.9M |
| FY21 | $2.8M |
| FY20 | $22.1M |
| FY19 | $5.7M |
| FY18 | $16.3M |
| FY17 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $13.2M |
| FY24 | $0 |
| FY23 | $0 |
| FY22 | $9.6M |
| FY21 | $0 |
| FY20 | $0 |
| FY19 | $1.5M |
| FY18 | $1.6M |
| FY17 | - |
- Viemed Healthcare
- Healthcare median
Show the numbers
| Year | Viemed Healthcare | Healthcare median |
|---|---|---|
| FY25 | 5.7% | −30.6% |
| FY24 | 5.1% | −47% |
| FY23 | 5.6% | −58% |
| FY22 | 4.5% | −80.4% |
| FY21 | 7.8% | −71.9% |
| FY20 | 24% | −62.2% |
| FY19 | 10.6% | −46.3% |
| FY18 | 14.7% | −49.6% |
| FY17 | - | −45.9% |